Research, Innovation & Clinical Trials

Precinct researchers, clinicians and companies collaborate and innovate at the contemporary convergence of health, science and engineering, empowered by digital technology,

This multidisciplinary approach positions the GCHKP to deliver next-generation medicine and advanced manufacturing, and comprehensive innovation in preventative and digital health care.

Personalised medicine

A brave new world

Leading-edge micro and nanoscience, together with 3D printing technology, supports the development of groundbreaking biomedical devices, implants and diagnostic tools in a brave new world of personalised medicine.

The latest in medical imaging technology combines with big data to enable biomechanical engineers to personalise training, prevent injury, design rehabilitation and model orthopaedic surgery. The ‘personalised digital human’ or ‘digital twin’ is fast moving from dream to reality.

Learn more

Advanced Medtech


A new frontier

Biomedical researchers on the drug discovery frontier of Glycomics hope to wipe out the global scourge of malaria. Full human clinical trials of a promising vaccine are set to commence after a pilot human study proved safe and successful.

With a range of infectious diseases and cancers firmly in their sights, the GCHKP’s world-leading Institute of Glycomics currently has two drug and two vaccine technologies in clinical trials.

Visit Institute for Glycomics

Leading the way in clinical trials

Beyond chronic disease and injury

New hope

A team of researchers is preparing for future clinical trials that combine 3D spinal regenerative cell therapy with specialised high-tech ‘thought control’ rehabilitation to repair spinal cord damage, giving hope for paraplegics and quadriplegics.

Others GCHKP researchers are closing in on a method of accurately diagnosing Chronic Fatigue Syndrome as they advance treatments for the debilitating condition.

Beyond Innovation

World's largest commercial glycan array